The Alzheimer’s Association and its advocacy affiliate, the Alzheimer’s Impact Movement (AIM), are lauding recent actions by lawmakers that will fund and advance multiple Alzheimer’s disease policies. The advancements are part of the $1.4 trillion government funding bill for the 2021 fiscal year that was passed by Congress on Dec. 21 and later signed into law by President Trump. The appropriations package includes a $300 million increase in Alzheimer’s and dementia research funding at the National Institutes of Health. It also…
You must be logged in to read/download the full post.
The post Support for Research, Patient Care in US 2021 Budget Wins Praise appeared first on BioNewsFeeds.